Entrada Therapeutics
TRDA
#6647
Rank
S$0.75 B
Marketcap
$20.09
Share price
-9.68%
Change (1 day)
-8.39%
Change (1 year)

Entrada Therapeutics (TRDA) - P/B ratio

P/B ratio as of January 2025 : 1.31

According to Entrada Therapeutics's latest financial reports the company has a price-to-book ratio of 2.57224.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Entrada Therapeutics - P/B ratio (from 2021 to 2024)

202220232024202523companiesmarketcap.com

P/B ratio by year

Year P/B ratio Change
2024-12-311.54-25.77%
2023-12-312.084%
2022-12-312.0011.67%
2021-12-311.79
2020-12-31N/A